Shukra Pharmaceuticals Ltd — Important, 10-09-2025: Company Update

Shukra Pharmaceuticals has secured a strategic PAN India distribution tie-up with Wockhardt Limited. This non-exclusive authorization allows Shukra to represent, distribute, and manage Wockhardt's products, including advanced anti-infective formulations like EMROK® and MIQNAF®, across all ESIC/ESIS and Defence Hospitals. This development significantly strengthens Shukra's presence in institutional and government healthcare networks, enhances revenue visibility, and expands its operational footprint across India, creating long-term value for shareholders.